首页> 外国专利> New N-((4,5-diphenyl-3-alkyl-2-thienyl)methyl)methyl amine derivatives are cannabinoids receptor inhibitor useful to treat or prevent e.g. gastro-intestinal disorders, inflammatory phenomena and diseases of the immune system

New N-((4,5-diphenyl-3-alkyl-2-thienyl)methyl)methyl amine derivatives are cannabinoids receptor inhibitor useful to treat or prevent e.g. gastro-intestinal disorders, inflammatory phenomena and diseases of the immune system

机译:新的N-(((4,5-二苯基-3-烷基-2-噻吩基)甲基)甲基胺衍生物是大麻素受体抑制剂,可用于治疗或预防例如胃肠道疾病,炎症现象和免疫系统疾病

摘要

N-[(4,5-Diphenyl-3-alkyl-2-thienyl)methyl]methyl amine derivatives (I) and their hydrates and solvates are new. N-[(4,5-Diphenyl-3-alkyl-2-thienyl)methyl]methyl amine derivatives of formula (I) and their hydrates and solvates are new. X : C(O), SO 2, C(O)N(R 6) or CO; R 11-7C alkyl, 3-7C cycloalkyl(methyl) (optionally substituted by 1-3C alkyl), phenyl (optionally mono, di- or - trisubstituted by halo, 1-4C alkyl, 1-4C alkoxy, CN, CF 3, OCF 3, S(O) n-Alk, 1-4C alkylcarbonyl or phenyl), benzyl (optionally substituted by halo, 1-4C alkyl, 1-4C alkoxy or CF 3) or indolyl; R 2H or 1-3C alkyl; R 31-5C alkyl or 3-7C cycloalkyl; R 4, R 5phenyl (optionally mono, di- or - trisubstituted by halo, 1-4C alkyl, 1-4C alkoxy, CN, CF 3 or S(O) n-Alk); R 6H or 1-3C alkyl; n : 0-2; and Alk : 1-4C alkyl. An INDPENDENT CLAIM is also included for the preparation of (I). [Image] ACTIVITY : Gastrointestinal-Gen.; Antiinflammatory; Immunomodulator; Neuroleptic; Antialcoholic; Antismoking; Anorectic; Eating-Disorders-Gen.; Antidiabetic; Antilipemic; Analgesic; Antianginal; Antidiarrheic; Antiulcer; Antiemetic; Uropathic; Endocrine-Gen.; Cardiovascular-Gen.; Hypertensive; Hemostatic; Immunosuppressive; Antibacterial; Hepatotropic; Antiasthmatic; Vasotropic; Ophthalmological; Antiinfertility; Antiarthritic; Antirheumatic; Neuroprotective; Virucide; Cerebroprotective; CNS-Gen.; Osteopathic; Nootropic; Tranquilizer. MECHANISM OF ACTION : Cannabinoids receptor inhibitor. The antagonistic activity of (I) against cannabinoids receptor was tested. The results showed that (I) exhibited a median inhibitory concentration =5x10 -7.
机译:N-[(4,5-二苯基-3-烷基-2-噻吩基)甲基]甲基胺衍生物(I)及其水合物和溶剂化物是新的。式(I)的N-[(4,5-二苯基-3-烷基-2-噻吩基)甲基]甲基胺衍生物及其水合物和溶剂化物是新的。 X:C(O),SO 2,C(O)N(R 6)或CO; R 11-7C烷基,3-7C环烷基(甲基)(可选被1-3C烷基取代),苯基(可选被卤素取代的单,二或三取代基,1-4C烷基,1-4C烷氧基,CN,CF 3 ,OCF 3,S(O)n-烷基,1-4C烷基羰基或苯基),苄基(可选被卤素,1-4C烷基,1-4C烷氧基或CF 3取代)或吲哚基; R 2H或1-3C烷基; R 31-5C烷基或3-7C环烷基; R 4,R 5苯基(任选被卤素,1-4C烷基,1-4C烷氧基,CN,CF 3或S(O)n-烷基单,二或-三取代); R 6H或1-3C烷基; n:0-2; Alk:1-4C烷基。还包括独立权利要求,用于制备(I)。 [图像]活动:胃肠道;消炎(药;免疫调节剂抗精神病药;抗酒;禁止吸烟;厌食的;饮食失调症抗糖尿病抗血脂;止痛药抗心绞痛止泻药抗溃疡;止吐药;尿毒症;内分泌根心血管创高血压;止血药免疫抑制抗菌;肝抗哮喘变压性眼科抗不孕症;抗关节炎抗风湿;具有神经保护作用;杀病毒剂;脑保护CNS-Gen .;整骨;促智;镇静剂。作用机理:大麻素受体抑制剂。测试了(I)对大麻素受体的拮抗活性。结果显示(I)表现出中值抑制浓度= 5×10 -7。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号